Medical Developments International (ASX:MVP) ROCE % : 1.31% (As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medical Developments International's annualized ROCE % for the quarter that ended in Dec. 2024 was 1.31%.

Medical Developments International ROCE % Historical Data

The historical data trend for Medical Developments International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International ROCE % Chart

Medical Developments International Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

0.57

-17.64

-18.07

-8.83

-48.52

Medical Developments International Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															8.16	-24.49	-30.76	-62.08	1.31

Medical Developments International ROCE % Calculation

Medical Developments International's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	-32.84	/	( ( (101.313 - 15.548)	+	(59.161 - 9.547) )	/ 2 )
	=	-32.84	/	( (85.765	+	49.614)	/ 2 )
	=	-32.84	/	67.6895
	=	-48.52 %

Medical Developments International's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	0.712	/	( ( (59.161 - 9.547)	+	(65.331 - 6.373) )	/ 2 )
	=	0.712	/	( ( 49.614	+	58.958 )	/ 2 )
	=	0.712	/	54.286
	=	1.31 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Medical Developments International (ASX:MVP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medical Developments International ROCE % Related Terms

Thank you for viewing the detailed overview of Medical Developments International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Developments International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MDDVF:USA

Address

4 Caribbean Drive, Scoresby, VIC, AUS, 3179

Website

https://www.medicaldev.com

Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Medical Developments International Stock Appears To Be Possible Value Trap

By GF Value • 01-01-1970

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire • 03-18-2022